Emergent BioSolutions Announces Board and Executive Changes
Ticker: EBS · Form: 8-K · Filed: Oct 4, 2024 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | Oct 4, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, governance, compensation
TL;DR
Emergent BioSolutions shakes up its board and exec pay, effective Oct 4.
AI Summary
Emergent BioSolutions Inc. announced on October 2, 2024, changes in its board of directors and executive compensation. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key executives. These changes are effective as of October 4, 2024.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, potentially impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- October 2, 2024 (date) — Date of earliest event reported
- October 4, 2024 (date) — Filing date and effective date of changes
- 300 Professional Drive, Gaithersburg, Maryland 20879 (address) — Principal executive offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates the departure of certain officers and the election of new directors, but does not specify the exact roles affected in this excerpt.
When are these changes effective?
The changes are effective as of October 2, 2024, with the filing dated October 4, 2024.
What is the primary reason for this 8-K filing?
The filing is to report on the departure of directors or certain officers, the election of directors, and compensatory arrangements of certain officers.
Where is Emergent BioSolutions Inc. headquartered?
Emergent BioSolutions Inc. is headquartered at 300 Professional Drive, Gaithersburg, Maryland 20879.
What is the company's SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-10-04 07:29:31
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share EBS New York Stock
Filing Documents
- ebs-20241002.htm (8-K) — 25KB
- 0001367644-24-000161.txt ( ) — 148KB
- ebs-20241002.xsd (EX-101.SCH) — 2KB
- ebs-20241002_lab.xml (EX-101.LAB) — 22KB
- ebs-20241002_pre.xml (EX-101.PRE) — 13KB
- ebs-20241002_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EMERGENT BIOSOLUTIONS INC. Dated: October 4, 2024 By: /s/ Jessica Perl Name: Jessica Perl Title: VP, Corporate Secretary and Interim General Counsel